DARPP32, a target of hyperactive mTORC1 in the retinal pigment epithelium.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
16 08 2022
Historique:
entrez: 8 8 2022
pubmed: 9 8 2022
medline: 11 8 2022
Statut: ppublish

Résumé

The mechanistic target of rapamycin (mTOR) is assembled into signaling complexes of mTORC1 or mTORC2, and plays key roles in cell metabolism, stress response, and nutrient and growth factor sensing. Accumulating evidence from human and animal model studies has demonstrated a pathogenic role of hyperactive mTORC1 in age-related macular degeneration (AMD). The retinal pigment epithelium (RPE) is a primary injury site in AMD. In mouse models of RPE-specific deletion of Tuberous sclerosis 1 (

Identifiants

pubmed: 35939707
doi: 10.1073/pnas.2207489119
pmc: PMC9388070
doi:

Substances chimiques

Dopamine and cAMP-Regulated Phosphoprotein 32 0
PPP1R1B protein, human 0
Ppp1r1b protein, mouse 0
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2207489119

Subventions

Organisme : NIEHS NIH HHS
ID : R01 ES031980
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY021725
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026999
Pays : United States

Références

J Cell Sci. 2011 Feb 15;124(Pt 4):523-31
pubmed: 21266465
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32196081
Neurosci Lett. 1991 Sep 30;131(1):66-70
pubmed: 1791981
J Clin Invest. 2011 Jan;121(1):369-83
pubmed: 21135502
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24100-24107
pubmed: 31712411
FASEB J. 2020 Sep;34(9):12502-12520
pubmed: 32721041
Front Behav Neurosci. 2011 Sep 08;5:56
pubmed: 21927600
Sci Rep. 2020 Feb 12;10(1):2464
pubmed: 32051464
Invest Ophthalmol Vis Sci. 2014 Dec 18;56(1):330-8
pubmed: 25525171
Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):9014-9019
pubmed: 30126999
Theranostics. 2019 Jan 30;9(4):1170-1180
pubmed: 30867823
Annu Rev Vis Sci. 2021 Sep 15;7:665-692
pubmed: 34102066
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Neuron. 1999 Jul;23(3):435-47
pubmed: 10433257
Eur J Neurosci. 2007 Jun;25(11):3233-42
pubmed: 17552992

Auteurs

Jiyang Cai (J)

Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.

Christopher Litwin (C)

Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.
Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.

Rui Cheng (R)

Department of Biochemistry, Wake Forest University Health Sciences, Winston Salem, NC 27157.

Jian-Xing Ma (JX)

Department of Biochemistry, Wake Forest University Health Sciences, Winston Salem, NC 27157.

Yan Chen (Y)

Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.
Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.
Department of Biochemistry, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH